Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Neurological
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Leukodystrophy
Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
Type of Organization: Charity
Contact Name: Omar Sherbini
Email Address: email@theglia.org
Funds Available for Clinical Trials: ✔ Research: ✔
Other info: Goal: To generate preliminary research data needed to secure more substantial funding through traditional federal, institutional, and/or industry grant mechanisms. Recognizing the importance of creating a sustainable infrastructure for collaborative research and excellence in clinical care, the GLIA-CTN Pilot Project Award is designed to enhance clinical trial readiness in the leukodystrophies through clinical/translational research in biomarkers, or assays to assess therapeutics, or other initiatives directed towards clinical trial readiness.
Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
Type of Organization: Charity
Contact Name: Omar Sherbini
Email Address: email@theglia.org
Funds Available for Clinical Trials: ✔ Research: ✔
Funding Details
Requirements: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible. There are also certain circumstances in which individuals with a PhD may be eligible. Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of funding (i.e., “high-risk/high-yield”) are encouraged.Other info: Goal: To generate preliminary research data needed to secure more substantial funding through traditional federal, institutional, and/or industry grant mechanisms. Recognizing the importance of creating a sustainable infrastructure for collaborative research and excellence in clinical care, the GLIA-CTN Pilot Project Award is designed to enhance clinical trial readiness in the leukodystrophies through clinical/translational research in biomarkers, or assays to assess therapeutics, or other initiatives directed towards clinical trial readiness.